Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2024 Benefit Year
April 26, 2024
No Comments
Relevant to: All Part D Plan Sponsors
Tag: All Part D Plan Sponsors
Categories
Technical Memorandum on the Changes to True Out-of-Pocket (TrOOP) Costs and the Calculation of the Maximum Monthly Cap for the Medicare Prescription Payment Plan
April 25, 2024
No Comments
Relevant to: All Part D Sponsors
Contract Year 2025 Bid Review Out-of-Pocket Cost (OOPC) Models
April 19, 2024
No Comments
Relevant to: Pharmaceutical Manufacturers; All Part D Plan Sponsors
Medicare Part D Manufacturer Discount Program: 2025 Participant List; Identification of Specified Manufacturers and Specified Small Manufacturers
April 4, 2024
No Comments
Relevant to: Pharmaceutical Manufacturers; All Part D Plan Sponsors
Final Medicare Part D DIR Reporting Guidance for 2023
March 14, 2024
No Comments
Relevant to: All Part D Plan Sponsors
Announcement of Global Reopening of the Part D Payment Reconciliation for Calendar Year 2022
January 2, 2024
No Comments
Relevant to: All Part D Plans, PACE Organizations
Calendar Year (CY) 2024 Resource and Cost-Sharing Limits for Low-Income Subsidy (LIS) – Correction
November 30, 2023
No Comments
Relevant to: All Part D Plan Sponsors
Completion of the 2022 Final Part D Payment Reconciliation
November 22, 2023
No Comments
Relevant to: All Part D Plan Sponsors, PACE
Application of Pharmacy Price Concessions to the Negotiated Price at the Point of Sale Beginning January 1, 2024
November 6, 2023
No Comments
Relevant to: All Part D Sponsors
Attestation of Prescription Drug Event (PDE) Data and Direct and Indirect Remuneration (DIR) Data related to the 2018 Reopening
November 3, 2023
No Comments
Relevant to: All Part D Plan Sponsors, PACE